Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Challenges and progress in developing herpesvirus vaccines

S C Inglis1

  • 1Cantab Pharmaceuticals Research Ltd., Cambridge, UK.

Trends in Biotechnology
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical service organisation for adults with atrial fibrillation: Cochrane systematic review and meta-analysis.

European journal of cardiovascular nursing·2025
Same author

Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.

Research in social & administrative pharmacy : RSAP·2016
Same author

Sex-specific time trends in first admission to hospital for peripheral artery disease in Scotland 1991-2007.

The British journal of surgery·2012
Same author

High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H.

Human gene therapy·1999
Same author

Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer.

Advances in experimental medicine and biology·1999
Same author

A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease.

The Journal of infectious diseases·1997
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
See all related articles

Developing vaccines for human herpesviruses is challenging due to their complexity. Recent advances in immunology and molecular biology offer promising new vaccine strategies, with several nearing human clinical trials.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Human herpesviruses cause a wide range of diseases, posing significant challenges for vaccine development.
  • Historically, progress in creating effective herpesvirus vaccines has been slow.
  • Recent breakthroughs in immunology and molecular biology are changing this landscape.

Purpose of the Study:

  • To review recent advances in human herpesvirus vaccine development.
  • To highlight promising new vaccination approaches.
  • To discuss the potential public health impact of upcoming herpesvirus vaccines.

Main Methods:

  • Review of recent scientific literature on herpesvirus vaccines.
  • Analysis of emerging immunological and molecular biology techniques.

Related Experiment Videos

  • Assessment of progress in pre-clinical and clinical vaccine trials.

    • Main Results:

    • New vaccination strategies show promise in model systems.
    • Several novel herpesvirus vaccines are in or near human clinical trials.
    • Technological advancements are accelerating vaccine development.

    Conclusions:

    • Advances in science and technology are revitalizing herpesvirus vaccine research.
    • New vaccines are expected to significantly reduce the burden of herpesvirus diseases.
    • A resurgence of interest in vaccination underscores its public health importance.